<VariationArchive VariationID="560465" VariationName="NM_001023570.4(IQCB1):c.1632_1638dup (p.Ala547fs)" VariationType="Duplication" Accession="VCV000560465" Version="9" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2018-09-10" MostRecentSubmission="2023-02-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="551527" VariationID="560465">
      <GeneList>
        <Gene Symbol="IQCB1" FullName="IQ motif containing B1" GeneID="9657" HGNC_ID="HGNC:28949" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="121769761" stop="121835060" display_start="121769761" display_stop="121835060" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="121488609" stop="121553925" display_start="121488609" display_stop="121553925" Strand="-" />
          </Location>
          <OMIM>609237</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001023570.4(IQCB1):c.1632_1638dup (p.Ala547fs)</Name>
      <CanonicalSPDI>NC_000003.12:121770503:TGCCACA:TGCCACATGCCACA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="121770503" stop="121770504" display_start="121770503" display_stop="121770504" variantLength="7" positionVCF="121770503" referenceAlleleVCF="C" alternateAlleleVCF="CTGCCACA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="121489350" stop="121489351" display_start="121489350" display_stop="121489351" variantLength="7" positionVCF="121489350" referenceAlleleVCF="C" alternateAlleleVCF="CTGCCACA" />
      </Location>
      <ProteinChange>A414fs</ProteinChange>
      <ProteinChange>A547fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.121489351_121489357dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.121489351_121489357dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.121770504_121770510dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.121770504_121770510dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015887.1" sequenceAccession="NG_015887" sequenceVersion="1" change="g.69570_69576dup">
            <Expression>NG_015887.1:g.69570_69576dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001023570.4" sequenceAccession="NM_001023570" sequenceVersion="4" change="c.1632_1638dup" MANESelect="true">
            <Expression>NM_001023570.4:c.1632_1638dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018864.2" sequenceAccession="NP_001018864" sequenceVersion="2" change="p.Ala547fs">
            <Expression>NP_001018864.2:p.Ala547fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001023571.4" sequenceAccession="NM_001023571" sequenceVersion="4" change="c.1233_1239dup">
            <Expression>NM_001023571.4:c.1233_1239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018865.2" sequenceAccession="NP_001018865" sequenceVersion="2" change="p.Ala414fs">
            <Expression>NP_001018865.2:p.Ala414fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001319107.2" sequenceAccession="NM_001319107" sequenceVersion="2" change="c.1632_1638dup">
            <Expression>NM_001319107.2:c.1632_1638dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001306036.1" sequenceAccession="NP_001306036" sequenceVersion="1" change="p.Ala547fs">
            <Expression>NP_001306036.1:p.Ala547fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_134968.2" sequenceAccession="NR_134968" sequenceVersion="2" change="n.1717_1723dup">
            <Expression>NR_134968.2:n.1717_1723dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="767295178" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001023570.4(IQCB1):c.1632_1638dup (p.Ala547fs) AND Retinal dystrophy" Accession="RCV000678578" Version="2">
        <ClassifiedConditionList TraitSetID="12366">
          <ClassifiedCondition DB="MedGen" ID="C0854723">Retinal dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001023570.4(IQCB1):c.1632_1638dup (p.Ala547fs) AND Nephronophthisis" Accession="RCV001360061" Version="5">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-31" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-31" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-09-10" MostRecentSubmission="2023-02-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-05-29">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-04-12">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12366" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18440" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinal dystrophy</ElementValue>
                <XRef ID="HP:0000556" DB="Human Phenotype Ontology" />
                <XRef ID="314407005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inherited retinal dystrophy</ElementValue>
                <XRef ID="MONDO:0019118" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18916" />
                <XRef ID="18916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="71862" DB="Orphanet" />
              <XRef ID="C0854723" DB="MedGen" />
              <XRef ID="D058499" DB="MeSH" />
              <XRef ID="MONDO:0019118" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000556" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007736" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007910" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007974" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007982" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1569336" SubmissionDate="2016-09-14" DateLastUpdated="2018-09-10" DateCreated="2018-09-10">
        <ClinVarSubmissionID localKey="NM_001023570.2:c.1632_1638dup|MedGen:C0854723" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000804660" DateUpdated="2018-09-10" DateCreated="2018-09-10" Type="SCV" Version="2" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IQCB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001023570.2:c.1632_1638dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Retinal dystrophy</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0854723" Type="CUI" />
          </Trait>
        </TraitSet>
        <StudyDescription>Variants as described in Haer-Wigman et al. 2016</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>haerwigman2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3062913" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="518948|MedGen:C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001555956" DateUpdated="2023-02-07" DateCreated="2021-04-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala547Cysfs*31) in the IQCB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 52 amino acid(s) of the IQCB1 protein. This variant is present in population databases (rs767295178, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of nephronophthisis (PMID: 23559409). ClinVar contains an entry for this variant (Variation ID: 560465). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IQCB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.121489350_121489351insTGCCACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3062913" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569336" TraitType="Disease" MappingType="Name" MappingValue="Retinal dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0854723" Name="Retinal dystrophy" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001523523</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

